InvestorsHub Logo

volgoat

03/12/13 8:35 PM

#116100 RE: TekNuLoof #116099

They discussed it at the end, but did not call it dose switching.
An analyst asked if they were taking precautions to prevent it from happening again. Called it unbelievable or something to that effect. Called it rare.

SK said they were taking precautions for future trials.